In addition, SKP2 overexpression was observed in several human malignancies, such as breast cancer, non-small-cell lung cancer, pancreatic cancer, gastric cancer, prostate cancer, melanoma, and hematological malignancies [29,30,31,32,33,34,35,36]. The gene discussed is SKP2; the disease is hematologic disorder.